Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Medpace Holdings Inc (MEDP)

Medpace Holdings Inc (MEDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Medpace Holdings Inc 5375 MEDPACE WAY CINCINNATI OH 45227 USA

www.medpace.com P: 513-579-9911 F: 513-579-0444

Description:

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.

Key Statistics

Overview:

Market Capitalization, $K 11,438,300
Enterprise Value, $K 11,192,850
Shares Outstanding, K 30,983
Annual Sales, $ 1,886 M
Annual Net Income, $ 282,810 K
Last Quarter Sales, $ 528,100 K
Last Quarter Net Income, $ 88,350 K
EBIT, $ 409,530 K
EBITDA, $ 435,860 K
60-Month Beta 1.35
% of Insider Shareholders 20.30%
% of Institutional Shareholders 77.98%
Float, K 24,693
% Float 79.70%
Short Volume Ratio 0.62

Growth:

1-Year Return 44.36%
3-Year Return 86.26%
5-Year Return 344.10%
5-Year Revenue Growth 167.65%
5-Year Earnings Growth 242.86%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 2.75 on 07/22/24
Next Earnings Date 10/28/24
Earnings Per Share ttm 10.63
EPS Growth vs. Prev Qtr -14.06%
EPS Growth vs. Prev Year 42.49%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

MEDP Ratios

Ratio
Price/Earnings ttm 33.99
Price/Earnings forward 30.60
Price/Earnings to Growth 1.85
Return-on-Equity % 55.14%
Return-on-Assets % 19.81%
Profit Margin % 15.00%
Debt/Equity 0.00
Price/Sales 5.94
Price/Cash Flow 35.40
Price/Book 14.48
Book Value/Share 24.63
Interest Coverage 686.06
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar